Physician-scientist-led careTrinidad & Tobago +
Exome & genome sequencing

Whole Genome Sequencing (WGS)

Genome-wide sequencing of coding and non-coding DNA, with broader variant analysis and individual or family-based interpretation options.

Understanding the test

Insight for a clinical question.

Whole genome sequencing examines coding and non-coding DNA to support investigation of inherited conditions. The workflow includes single-nucleotide variants, small insertions and deletions, copy-number and structural analysis, with individual, duo or trio interpretation options. Selected repeat-region and pharmacogenomic analyses may also be relevant to the order. Ask Genomika which findings are validated and reported for your clinical question; genome-wide sequencing does not identify every possible genetic cause.

How it is analysed

PCR-free whole-genome next-generation sequencing with clinically directed variant analysis and optional family comparison.

What is included

Analysis & options.

WGS is genome-wide rather than a fixed gene panel. A static gene count does not describe its reportable scope. Ask about the genes, regions and variant classes relevant to the clinical question.

Analysis scope

Coding and non-coding DNA

Genome-wide sequence data provide context beyond protein-coding regions.

Variant classes

Single-nucleotide variants and small insertions/deletions

Sequence-variant analysis within the selected reportable scope.

Copy-number and structural variants

Analysis of broader variant classes; reportable sizes and types depend on the assay.

Additional analysis

Selected tandem-repeat regions

Selected VNTR analysis; detection of a specific disease-causing repeat expansion requires confirmation of assay scope.

Pharmacogenomic analysis

Medication-related interpretation can be part of the genome workflow; ask for the specific reportable targets.

Family options

Individual, duo or trio interpretation

Interpretation can use one person’s data or comparisons with one or two family members.

In clinical context

Understanding the scope.

Choosing a test means considering both the genes or regions examined and the types of changes it can detect.

  • The reportable scope depends on the analysis selected and validated performance for each variant class.
  • A broad sequencing approach does not guarantee detection of all repeat expansions, balanced rearrangements, mosaic findings or mitochondrial variants.
  • Specialized findings may need an additional method or confirmatory testing.
  • Single-person, duo and trio approaches are available; the most useful approach depends on the clinical question and available family samples.

Your next step

Discuss this test
with Genomika.

We’ll discuss the clinical question and confirm testing arrangements, sample requirements, costs and reporting times.

Enquire about this test
← Back to all tests and panels

Website privacy

Your information.

The general enquiry form prepares an email in your own email application. Form entries are not submitted to a website database or stored in your browser by this site.

If you choose to send an email, the information is handled by your email provider and received by Genomika at the displayed email address. This form is intended for general enquiries only; please do not send medical records or sensitive health information through it.

This website does not add analytics or marketing cookies. The hosting service may process technical information needed to serve the site and manage access. Please contact Genomika to discuss an appropriate route for sharing clinical information.